Loading...
Back to narrative

Update shared on05 Sep 2025

Fair value Increased 8.62%
AnalystConsensusTarget's Fair Value
US$162.30
15.3% undervalued intrinsic discount
05 Sep
US$137.45
Loading
1Y
53.4%
7D
-2.9%

The increase in JBT Marel’s consensus analyst price target to $162.30 is primarily driven by a higher forecast valuation multiple (Future P/E), with revenue growth expectations remaining steady.


What's in the News


  • JBT Marel re-established full year 2025 earnings guidance, projecting revenue of $3,675 million to $3,725 million, a loss from continuing operations margin of 2.7% to 1.7%, and GAAP loss per share of $1.90 to $1.20.
  • 2025 revenue outlook includes a $70 million to $85 million year-over-year tailwind from foreign exchange translation.
  • JBT Marel was added to the Russell 2000 Dynamic Index.

Valuation Changes


Summary of Valuation Changes for JBT Marel

  • The Consensus Analyst Price Target has risen from $149.42 to $162.30.
  • The Future P/E for JBT Marel has risen from 20.38x to 22.13x.
  • The Consensus Revenue Growth forecasts for JBT Marel remained effectively unchanged, moving only marginally from 19.0% per annum to 18.9% per annum.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.